Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Trial details
- Registry ID
- NCT06989359
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2 Study of ADX-038 in Complement-Mediated Kidney DiseaseNCT06989359 | ADRX | Phase 2 | Recruiting | 2030-04-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |